Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Cytosolic Lipid Droplets in Hepatitis C Virus Replication, Assembly, and Release. | Biomed Res Int | 2023 | 37090186 | PubTator, text mining | PubMed |
| Crosstalk between microglia and neural stem cells influences the relapse of glioblastoma in GBM immunological microenvironment. | Clin Immunol | 2023 | 37088298 | PubTator, text mining | PubMed |
| Tumor and immune remodeling following radiotherapy in human renal cell carcinoma. | J Immunother Cancer | 2023 | 37080610 | PubTator, text mining | PubMed |
| PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells. | Commun Med (Lond) | 2023 | 37076593 | PubTator, text mining | PubMed |
| Pleiotropic loci for cannabis use disorder severity in multi-ancestry high-risk populations. | Mol Cell Neurosci | 2023 | 37061172 | PubTator, text mining | PubMed |
| Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma. | Front Immunol | 2023 | 37056756 | PubTator, text mining | PubMed |
| Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients. | Cells | 2023 | 37048072 | PubTator, text mining | PubMed |
| Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways. | Cancers (Basel) | 2023 | 37046795 | PubTator, text mining | PubMed |
| Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection. | Commun Biol | 2023 | 37029220 | PubTator, text mining | PubMed |
| Deep learning-based polygenic risk analysis for Alzheimer's disease prediction. | Commun Med (Lond) | 2023 | 37024668 | PubTator, text mining | PubMed |
| Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma. | Front Immunol | 2023 | 37006234 | PubTator, text mining | PubMed |
| Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration. | Nat Aging | 2023 | 36993867 | PubTator, text mining | PubMed |
| Leveraging gene correlations in single cell transcriptomic data. | bioRxiv | 2023 | 36993765 | PubTator, text mining | PubMed |
| Identification of Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs for Xp11 Translocation Renal Cell Carcinoma (RCC) Based on Whole-Transcriptome Sequencing. | Genes (Basel) | 2023 | 36980995 | PubTator, text mining | PubMed |
| Transcriptomic Studies on Intracranial Aneurysms. | Genes (Basel) | 2023 | 36980884 | PubTator, text mining | PubMed |
| How can childhood maltreatment affect post-traumatic stress disorder in adult: Results from a composite null hypothesis perspective of mediation analysis. | Front Psychiatry | 2023 | 36970281 | PubTator, text mining | PubMed |
| APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis. | Pathol Oncol Res | 2023 | 36969562 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals underlying host responses in pediatric respiratory syncytial virus pneumonia. | iScience | 2023 | 36968072 | PubTator, text mining | PubMed |
| Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology. | Front Endocrinol (Lausanne) | 2023 | 36967758 | PubTator, text mining | PubMed |
| DIA-based technology explores hub pathways and biomarkers of neurological recovery in ischemic stroke after rehabilitation. | Front Neurol | 2023 | 36959823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=24